Naltrexone Completed Phase 1 / 2 Trials for Alcohol Dependence / Bipolar Disorder (BD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01738867To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
NCT00769158Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study